Recently, Fertsy Inc announced the completion of an angel round of financing worth several million RMB, led by Xishan Angel Club. This financing will be used to further promote the company’s R&D innovation, market expansion, and team building in the field of AI-assisted reproduction.
Xishan Angel Club is a well-known early-stage investment institution in China, long focusing on technological innovation, with rich investment experience and resource integration capabilities. As an early investor in China’s first publicly listed AI medical company, Xishan Angel Club has numerous successful investment cases in the health and artificial intelligence sectors.
Xishan Angel Club stated that Fertsy has clear technological advantages in the field of AI-assisted reproduction, and is gradually building a series of intelligent medical device hardware and software products for assisted reproduction, helping domestic and international fertility centers improve success rates and service accessibility, showing great potential in the transformation and development of assisted reproductive technology.
We are deeply grateful for Xishan’s trust and support, and will seize this financing opportunity to accelerate our growth and create greater value in AI-assisted reproduction. We also look forward to collaborating with industry peers, both domestically and internationally, as well as upstream and downstream partners, to jointly drive technological innovation and development in the assisted reproduction field.
About Fertsy Inc:
Fertsy Inc was founded in 2023 and is a startup dedicated to improving the success rate and accessibility of assisted reproduction. Leveraging new technologies such as artificial intelligence, robotics, and advanced manufacturing, it is building a new generation of assisted reproduction laboratories.